| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |